Assessing capacity for health policy and systems research in low and middle income countries* by Gonzalez Block, Miguel A & Mills, Anne
Gonzalez Block, M; Mills, A (2003) Assessing Capacity for Health
Policy and Systems Research in Low and Middle Income Countries.
Health Research Policy and Systems, 1 (1). pp. 1-20. DOI: https://doi.org/10.1186/1478-
4505-1-1
Downloaded from: http://researchonline.lshtm.ac.uk/12255/
DOI: 10.1186/1478-4505-1-1
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons: Attribution-No Derivative Works 3.0
http://creativecommons.org/licenses/by-nd/2.5/
BioMed Central
Page 1 of 20
(page number not for citation purposes)
Health Research Policy and Systems
Open AccessResearch
Assessing capacity for health policy and systems research in
low and middle income countries*
Miguel A Gonzalez Block*1 and Anne Mills1,2
Address: 1Alliance for Health Policy and Systems Research, World Health Organisation. CH 1211 Geneva 27, Switzerland and 2Department of 
Health Economics and Policy, London School of Hygiene and Tropical Medicine, UK
Email: Miguel A Gonzalez Block* - blockm@who.ch; Anne Mills - anne.mills@lshtm.ac.uk
* Corresponding author    
Abstract
Background: As demand grows for health policies based on evidence, questions exist as to the
capacity of developing countries to produce the health policy and systems research (HPSR)
required to meet this challenge.
Methods: A postal/web survey of 176 HPSR producer institutions in developing countries
assessed institutional structure, capacity, critical mass, knowledge production processes and
stakeholder engagement. Data were projected to an estimated population of 649 institutions.
Results: HPSR producers are mostly small public institutions/units with an average of 3 projects,
8 researchers and a project portfolio worth $155,226. Experience, attainment of critical mass and
stakeholder engagement are low, with only 19% of researchers at PhD level, although researchers
in key disciplines are well represented and better qualified. Research capacity and funding are
similar across income regions, although inequalities are apparent. Only 7% of projects are funded
at $100,000 or more, but they account for 54% of total funding. International sources and national
governments account for 69% and 26% of direct project funding, respectively. A large proportion
of international funds available for HPSR in support of developing countries are either not spent or
spent through developed country institutions.
Conclusions: HPSR producers need to increase their capacity and critical mass to engage
effectively in policy development and to absorb a larger volume of resources. The relationship
between funding and critical mass needs further research to identify the best funding support,
incentives and capacity strengthening approaches. Support should be provided to network
institutions, concentrate resources and to attract funding.
Background
Health policy and systems research (HPSR) is increasing
in prominence in low and middle income countries, stim-
ulated by social and political pressure towards health sys-
tem equity and efficiency. Yet the institutional capacity to
fund and produce quality research and to have a positive
impact on health system development has been little ex-
amined and touches mainly on specific areas such as ma-
laria research or the impact of research on health reforms
[1–6]. In general, however, there is increasing pressure to
direct research investments on the basis of evidence of
policy relevance and impact [7–13]. Indeed, in this dec-
ade of efforts to link development, health and research
world-wide, there is little enquiry into the role of scientific
capacity in general [14].
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This paper seeks to develop an empirical basis for assisting
decisions on what are likely to be good investments to in-
crease capacity in health policy and systems research (HP-
SR) in developing countries. It presents the results of a
survey undertaken by the Alliance for Health Policy and
Systems Research (Alliance-HPSR) in 2000 and 2001 to
analyse institutional structure and characteristics, engage-
ment with stakeholders, institutional capacity, level of at-
tainment of critical mass and the process of knowledge
production by institutions in low and middle income
countries.
Low and middle income countries account for 4.9 billion
of the world's 6 billion people. Identifying research capac-
ity for a specific field such as HPSR in such a large context
is daunting. Yet it is becoming ever more important to as-
sess gaps and resource requirements, particularly for the
low income regions of the world that are the targets of in-
itiatives such as the Global Fund for AIDS, Malaria and
Tuberculosis. Regional-level analysis is also of importance
to WHO and research networks, agencies and donors with
a particular interest at this level.
The Alliance for Health Policy and Systems Research http:/
/www.alliance-hpsr.org was established with the collabo-
ration of the World Health Organisation and the Global
Forum for Health Research in November 1999 with the
aim of contributing to health development and the effi-
ciency and equity of health systems through research on
and for policy. Alliance objectives include promoting re-
search capacity on national and international issues, de-
veloping the information for policy decisions, stimulating
the generation of knowledge, strengthening international
research collaboration, identifying global level influences
on health systems and promoting appropriate research.
Alliance activities are carried out with the support of
WHO and the collaboration of regional networks. Activi-
ties focus on low and middle income countries outside
WHO's European region, where other programmes sup-
porting HPSR.are in operation (such as the European
Health Observatory, http://www.who.dk/observatory). A
grants program is in operation and technical analyses
have focused in the area of capacity assessment, capacity
strengthening and the analysis of the characteristics in the
research to policy process. Technical support is provided
to partners in proposal development and in the develop-
ing dissemination and research impact strategies. The Al-
liance encourages partnership from institutions
producing, supporting or funding HPSR research, as well
as from users of evidence for policy in developing coun-
tries. To date over 300 institutions have joined as partners,
and direct contacts have been established with over 700
institutions.
The Commission on Health Research for Development
drew attention to the importance of health research as an
"essential link to equity and development" [15]. It pro-
posed that low and middle income countries should re-
view and strengthen the management of health research
so as to meet their national needs as well as contributing
to the global fund of knowledge. Furthermore, the Com-
mission proposed that governments in low and middle
income countries should allocate at least 2% of national
health expenditures and 5% of externally funded pro-
grammes to research and capacity strengthening. Capacity
strengthening, for the Commission, encompassed indi-
vidual capacity, institutional infrastructure that supports
research, the research component of policy formulation
and field action, and global health research.
Following these lines, HPSR capacity is here defined as the
level of expertise and resources at the researcher, project
and institutional levels for the production of new knowl-
edge and applications to improve the social response to
health problems. Capacity to engage stakeholders in poli-
cy and programme development is included. Institutions
are defined as groups of collaborating professionals dedi-
cated to HPSR within a legal entity or a unit of a larger le-
gal entity (such as a health policy research unit within a
school of public health or a ministry of health).
HPSR was defined by the Alliance as knowledge genera-
tion to improve how societies organise themselves to
achieve health goals, including how they plan, manage
and finance activities to improve health, as well as the
roles, perspectives and interests of different actors in this
effort. HPSR contributes to sound, socially relevant and
ethically acceptable guidance for more effective, efficient
and sustainable health policies and systems. The health
system functions of regulation, organisation, financing
and delivery of services are the focal subjects of HPSR.
Broader determinants directly affecting the health system
are also considered within the purview of HPSR, such as
social and economic policies affecting key health system
structures and processes.
The Global Forum for Health Research classified health
research and development (R&D) funding according to
per capita income level of the source and recipient coun-
tries and by topic, including HPSR [16]. The analysis of
HPSR funding in this study floows Global Forum's classi-
fications and focuses mainly on international funding for
national health research in low and middle income coun-
tries, and on funding from governments and private
sources within countries. An important caveat, however, is
that these 2 categories are difficult to distinguish in prac-
tice, since much donor funding flows through
governments.
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Together with funding, the question of project initiation
was considered, as it reflects on the priorities followed for
the research, as well as the degree of autonomy on the part
of research institutions. The role of government in initia-
tion is distinguished from that of international donors
and contractors, while the role played by the research in-
stitution itself is also identified.
Methods
The assessment considers six strategic and interrelated
groups of variables: institutional/country context and
characteristics, institutional capacity and engagement
with stakeholders, attainment of critical mass of research-
ers to produce quality, sustainable research, and the proc-
ess of knowledge production (project portfolio
characteristics, including external research project fund-
ing). While no output data were obtained to assess the at-
tainment of critical mass or quality (such as publications),
some indicators are explored as a step towards further re-
search in this area. Most attention is given to describing
capacity indicators and their relationships, mostly com-
paring their distribution across contrasting country con-
texts as measured by gross national per capita income.
Given the lack of knowledge on what constitutes an ideal
level or composition of capacity, indicators used should
be regarded as tentative. Figure 1 summarises the key ca-
pacity variables and the indicators available to assess
them.
The survey
The Alliance-HPSR recruits institutional partners on the
basis of common aims towards producing and using
HPSR in developing countries, irrespective of the size or
legal status of the institution or unit. Partners are request-
ed to provide a 30 question profile in order to assist the
Alliance maintain a continuous assessment of capacity to
produce, demand or support HPSR, including countries in
both North and South. This study involves all 176 Alli-
ance partner institutions producing HPSR in low and mid-
dle income countries. Most of the data (78%) are for
2000, although data for 1999 (8%)and for 2001 (14%)
are also included. The questionnaire comprised sections
on structure, projects, institutional environment and ca-
pacity development. The database was coded and cleaned
prior to processing.
A total of 108 questionnaires for the 176 HPSR producers
in developing countries were sent in or Web posted (61%
response rate) (table 1). Biases could have occurred at two
levels: the request for partnership and the response to the
questionnaire. Over-representation at both levels could
have occurred of more competitive and productive insti-
tutions with larger project portfolios and funding, and
more interest in international funding. On the other
hand, larger institutions may have been discouraged from
responding given the larger number of projects to be re-
ported, although they would also have more capacity to
respond. Furthermore, the response rate could have been
lower among institutions where producing HPSR is not a
main function.
Estimating the population of HPSR producer institutions
HPSR occurs at many levels and no single assessment will
ever capture all the players. For this study the population
of HPSR producers in low and middle income countries
outside Europe was approximated by focusing on the sub-
set of HPSR institutions that contacted the Alliance be-
tween 1999 and 2001 seeking funding opportunities and,
to a lesser extent, general information. Close collabora-
tion with 4 regional HPSR networks ensured contact with
all the major HPSR producers in Latin America, Africa,
South and South East Asia and China.
Between 2000 and 2002 the Alliance launched calls for
brief three-page letters of intent for funding of HPSR
projects, with a total response of 780 valid applications
from developing country researchers. During this period,
the Alliance also encouraged institutions to apply for part-
nership, for which 309 were recruited. As a result of these
appeals a total of 607 research-producing institutions in
77 low and middle income countries outside WHO's Eu-
ropean region were contacted (table 1), of which 176 are
Alliance partners from 39 countries. It is likely that the
609 institutions are very close to the total number of
HPSR producers in developing countries given the wide
appeal made by the Alliance in collaboration with WHO
at country level.
A total of 56 developing countries, contributing as a
whole 6.6% of the developing country population, were
not reached by the Alliance. Eleven of the 34 countries
larger than 1 million inhabitants are in the Middle East or
Central Asia and only 3 in Latin America. To ensure these
57 countries are included in the extrapolations, the ex-
pected number of institutions was estimated by assuming
the same population coverage as in the countries reached
within each of the three income groups (table 1). This
procedure may have over-inflated the number of existing
institutions, as not all countries, particularly the smaller,
low-income ones, necessarily have HPSR producers. How-
ever, this may be compensated for by the under-represen-
tation of smaller HPSR producers in the larger countries
that were reached.
Countries surveyed amount to 29% of the total of low and
middle income outside Europe, with a somewhat greater
inclusion of low income countries (which could reflect
their greater interest in international resources). Institu-
tions surveyed correspond to 17% of those expected in the
countries considered, with a distribution across income
Health Research Policy and Systems 2003, 1 http://www.health-policy-systems.com/content/1/1/1
Page 4 of 20
(page number not for citation purposes)
Figure 1
Variables and indicators in the assessment
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groups which is almost identical. While the proportion of
institutions surveyed is lower than would be desirable to
reach robust conclusions, the very close match between
sampled and contacted institutions across income groups
lends support for both comparisons and extrapolations.
None-the-less, extrapolations should be considered only
tentative at this stage, and need to be confirmed through
other approaches. In particular, surveying a higher pro-
portion of institutions would provide more reliable infor-
mation on the size and make-up of institutions.
Estimations
Project duration was obtained through a categorical ques-
tion with 3 brackets between 1 and 24 months and one for
projects with longer duration. A numerical figure was esti-
mated by using the mid point of each category and cap-
ping duration at 2 years for the small fraction of projects
at this level. The questions on funding for research en-
quired about project funding external to the institution,
that is, financing for research received from national or in-
ternational donors or from government or private agen-
cies. Core funding to institutions was not included.
Project funding was obtained for each project listed using
a categorical question with six funding brackets between
$0 and $99,999. Funding for projects below $100,000
was estimated by assigning to each project the middle
point in its bracket. The questionnaire asked for projects
funded above this figure to be indicated, and the specific
funding amount and project duration were obtained
through a follow-up telephone or e-mail request. Details
could not be obtained for only 5 out of the 26 projects in
this category, and these were assessed at $100,000 and 2
years duration.
Annual project expenditure and total annual funding were
estimated by annualising total costs for projects over a
year and considering all costs for projects under a year. To-
tal human resources, number of HPSR projects and
project funding were estimated by scaling up survey re-
sults by the share of institutions in the population for
each income group of countries. However, this weighting
was minimal given the very close match between the pro-
portions of institutions surveyed and those in the popula-
tion for each income group.
Data grouping and aggregation
Data are analysed for institutions, researcher workforce,
projects and total funding. In each case, the countries' per
capita gross national income is used to group and aggre-
gate data. The categories used are those from the World
Bank: Low Income Countries (LICs) with $755 or less,
Lower Middle Income Countries (LMICs) between $756
and $2,995, and Upper Middle Income Countries (UM-
ICs) between $2,996 and $9,265.
Surveyed institutions are mostly distributed in LICs
(46%), with 33% LMICs and 20% UMICs (see figure 2 for
list of countries). LICs with most sampled institutions are
(in order) India, Bangladesh, Pakistan, Indonesia, Kenya,
Uganda and Ghana. Those for LMICs are China, Colom-
bia, Philippines, Thailand, Bolivia, Cuba and Sri Lanka;
while those for UMICs are Argentina, Brazil, South Africa,
Mexico, Korea, Rep., Uruguay and Chile.
Results
Institutional characteristics and capacity
Research institutions provide a basic context for project
teams and researchers through the values they embody
which will vary according to the public, private or mixed
legal status of institutions as well as their national or in-
ternational mission. The experience of institutions indi-
cates their research capacity, stability and ability to
Table 1: Institutions Surveyed, Contacted and Total in the Population, by Income Group
Level of 
Income
Surveyed Contacted Total in Population
Institutions Countries Institutions Countries Institutions* Countries
No. % No. % No. % No. % No. % No. %
Low (LI) 
<$756
50 46 21 54 268 44 34 44 294 45 58 44
Lower Mid-
dle (LM) 
$756–$2,995
36 33 10 26 188 31 27 35 193 30 44 33
Upper mid-
dle (UM) 
$2,996–$9265
22 20 8 21 151 25 16 21 162 25 31 23
TOTAL 108 100 39 100 607 100 77 100 649 100 133 100
*Total institutions in the population were estimated through calculating the ratio of contacted institutions per population within each of UM, LM & 
LI countries and then expanding to the total population in each region.
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Figure 2
Countries Surveyed by Income Group
Low Income (LIC)
Low Middle Income 
(LMIC)
Upper Middle Income 
(UMIC
Bangladesh Algeria Argentina
Benin Bolivia Brazil
Burkina Faso China Chile
Burundi Colombia Costa Rica
Cambodia Cuba Korea, Rep.
Cameroon Ecuador Lebanon
Congo, Dem. Rep Egypt, Arab Rep. Malaysia
Cote d'Ivoire El Salvador Mauritius
Ethiopia Guatemala Mexico
Gambia, The Guyana Panama
Ghana Honduras South Africa
Guinea-Bissau Iran, Islamic Rep. St. Kitts and Nevis
Haiti Iraq Trinidad and Tobago
India Jamaica Turkey
Indonesia Kazakhstan Uruguay
Kenya Morocco Venezuela, RB
Kyrgyz Republic Namibia
Lao PDR Papua New Guinea
Malawi Peru
Mali Philippines
Mongolia Samoa
Myanmar Sri Lanka
Nepal Suriname
Nicaragua Swaziland
Nigeria Thailand
Pakistan Tunisia
Senegal
Sudan
Tanzania
Uganda
Vietnam
Zambia
Zimbabwe
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contribute to cross-institutional support. Staff incentives
are key for retention while they, together with access to in-
formation technology, contribute to the quality of out-
puts. The overall qualifications of the research workforce,
together with the project investment and the size of the
portfolio, contribute also to the context in which projects
operate and critical mass is attained.
Legal status and scope
Public institutions constitute 64% of the total, private
29% and mixed public-private 7% (table 2). One quarter
of private institutions are for profit. The proportion of pri-
vate institutions in the Americas is greater than in the oth-
er regions, with 40%, against only 29% and 19% for Asia
and Africa, respectively. The public-private distribution of
institutions across income groups is interesting: in UMICs
and LICs private and mixed institutions account for as
many as 46% of the total, with only 17% in LMICs (where
China weighs heavily). Private institutions are significant-
ly larger, with 13.5 researchers on average, against 8.2 for
their public counterparts. Both legal types have similar
shares of full time resources, although public institutions
have a somewhat larger share of PhDs in their research
workforce, with 24% against 14%. Half (51%) of
Table 2: Characteristics and Capacity of Institutions Doing HPSR
TOTAL Per Capita GNP
Low Lower Middle Upper Middle
No. % No. % No. % No. %
Total No. 108 100 50 46 36 33 22 20
Legal status
Private 31 29 17 34 5 14 9 41
Public 69 64 27 54 30 83 12 55
Mixed public/private 8 7 6 12 1 3 1 5
Experience
Less than 1 year 7 6 3 7 2 6 1 5
1 to 2 4 4 2 4 1 3 1 5
3 to 5 22 20 9 17 7 18 7 30
6 to 10 29 27 16 33 8 21 6 25
Over 10 years 46 42 20 39 19 52 8 35
TOTAL 108 100 50 100 36 100 22 100
Information technology
No/rare PC access 8 7 7 14 1 3 0 0
No Internet 5 4 4 7 1 3 0 0
FTE* researcher base
FTE per institution 8.4 9.7 7.0 8.0
No. of institutions with: 2 
FTE or less
17 16 8 16 7 21 2 10
>2 to 4 22 20 8 16 10 28 4 19
5 to 10 37 34 13 26 11 31 12 52
More than 10 32 30 21 42 7 21 4 19
PhDs in workforce
Zero PhDs 26 24 7 14 7 21 10 48
1 to 2 53 49 28 57 20 55 6 29
3+ 29 26 15 30 9 24 5 24
Project portfolio
Total projects 3.0 2.8 2.9 3.4
Projects <1 year 2.3 2.0 2.3 2.5
Project funding
Total for portfolio ** $155,226 $150,806 $178,636 $126,470
Annually $80,521 $72,140 $111,879 $81,901
Databases and publications for decision makers
Producer 45 42 23 46 11 31 11 50
* FTE: Full Time Equivalent. Indicates the total number of person/months employed by including full time and part time researchers under a single 
category. **Includes total project funding for all projects within the institution and their entire duration.
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institutions are exclusively national in scope of activities,
while the other half also consider themselves active at the
international level.
Experience
Institutions with over 10 years of experience account for
42% of the total (table 2). Those newer to the field include
47% with 3 to 10 years and 10% with less than three years
of activities. 6% of the total have less than a year of expe-
rience. There are marked differences in the experience of
HPSR institutions across regions and income groups. In
Africa only 21% of institutions have had more than 10
years of experience, against 46% in Asia and 59% in the
Americas. LMICs have the highest proportion of institu-
tions with over 10 years of experience (52%) while the
proportion of institutions across income regions with less
than a year's experience is very similar.
The research experience of the director or person respon-
sible for the unit undertaking HPSR as measured in years
of activity closely matches the experience of the research
institution (corr = 0.51), suggesting that, in most cases,
new institutions are not being formed by experienced re-
searchers, but rather heads become seasoned in HPSR
while in the post. The most experienced institutions tend
to have larger numbers of researchers (corr = 0.20),
though there is no correlation with the proportion of
PhDs (corr = 0.09). The more experienced institutions
also tend to have a larger funding portfolio (corr = 0.20).
Incentives
Researchers work mainly in universities and other aca-
demic environments. It is therefore not surprising that the
most common career development incentive consists of
opportunities to attend conferences and meetings and
support for training and education (95% and 93% of re-
spondents identify these as very or fairly important to re-
tain personnel). Opportunities to engage in consulting are
at least fairly important for 89% of respondents, a figure
which is very similar for both public and private institu-
tions. Less important, but still highly valued incentives,
are bonuses (59%) and pay rises tied to productivity
(64%). These pecuniary incentives are more valued in pri-
vate institutions (39% of private vs. 28% of public institu-
tions consider very important bonuses tied to
productivity, while these figures are 31% and 15% for pe-
riodic pay rises tied to productivity).
Information technology
Researchers have no or rare access to personal computers
in only 5% of institutions, affecting mostly LICs, with
14% of institutions in this situation. Up to 60% of insti-
tutions are well connected to the internet (all or most of
their computers are linked) while 11% have no or rare ac-
cess. IT infrastructure is less developed in Africa, where
19% of institutions have no or rare access to PCs for their
researchers. Regarding Internet access in this geographical
region, this is rare or null in 27% of institutions, against
only 2% and 4% for Asia and the Americas, respectively.
Research workforce
Out of the total researcher workforce surveyed, 68% are
full time and 19% have a PhD (table 3). In LICs there is a
higher concentration of PhDs, with 21% of the total on
average, against 18% in LMICs and 14% in UMICs. Inter-
estingly, in Africa PhDs account for as many as 26% of the
total workforce, against 20% in Asia and 14% in the
Americas. These figures suggest that training is not the
main disadvantage in LICs and in Africa relative to other
regions.
In LICs, full time dedication to research is as high as 81%,
dropping to the low 50%s in the other groups. The more
qualified researchers are more likely to have full time ded-
ication: 95% for Masters and 68% for PhDs, against only
49% for Bachelors.
Table 3: Researcher Characteristics
TOTAL Per Capita GNP
Low Low Middle Upper Middle
Total FTE researchers 909 483 251 175
% full time 68 81 55 51
Total PhD 169 100 44 25
% PhD 19 21 18 14
Project funding per researcher $15,198 $13,426 $20,637 $12,286
Annual project funding per 
researcher
$7,618 $5,370 $12,035 $7,488
FTE per project 2.8 3.5 2.4 2.3
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Total project funding per researcher is $10,300, being
lowest in LICs at $8,500 and highest in LMICs at around
$12,900. Project funding per researcher expressed on an
annual basis is on average $6,500, lowest in LICs at
$5,900 and highest at $7,300 in LMICs. These differences
are explained not by funding levels per project but a by a
lower number of researchers per institution and per
project in LMICs relative to other regions (see below).
Research portfolio
Out of the total institutions, 11% report no research
projects for the current year, although they are seeking op-
portunities to undertake research. On average the HPSR
project portfolio contains 3.0 projects. Institutions in UM-
ICs have an average of 3.4 projects, against 2.9 and 2.8 for
LMICs and LICs, respectively. Most institutions (58%)
have 3 to 4, while 29% have 1 to 2. Only 13% have more
than 4 projects. As a whole, 76% of the project portfolio
is of less than one year's duration, a figure which is as high
as 80% for LMICs.
Based on the proportion of projects under one year's du-
ration it can be estimated that institutions initiate on av-
erage 2.3 projects per year, a high number when it is
considered that there are 3.7 researchers per project initi-
ated and 0.7 PhDs (table 3), and that for each funded
project there will be several unsuccessful proposals. In
LMICs there are 3.0 researchers per project initiated, as
against 4.5 for LICs.
The average institution's research portfolio is worth
$155,000 in project funding, of which $80,500 is spent
annually. Average portfolio funding is similar across in-
come regions. Most institutions (45%) have a portfolio
worth less than $50,000, 15% between this figure and
$99,000, 25% between $100,000 and $199,000 and only
15% have a portfolio worth over $100,000. However, two
institutions in Colombia and one in Pakistan have ex-
tremely high research portfolios, worth over $1 million.
Attainment of critical mass
Attainment of critical mass can be defined in theory as the
grouping of a minimum number of researchers within a
single institution with the right mix of qualifications and
disciplines as to be able to produce quality HPSR in a sus-
tainable way. In practice, there are no clear standards of
what constitutes a minimum number or right mix, so
analysis here is tentative. Clearly, the institutional and
country contexts will influence the attainment of critical
mass.
Size of researcher work force
Each institution relies on average on 8.4 researchers, rang-
ing from 9.7 in LICs to 7.0 in LMICs (table 2). While only
19% of institutions in LMICs and 21% in UMICs are larg-
er than 10 researchers, 42% of those in LICs are in this cat-
egory (figure 3). However, many of the smaller
institutions constitute units within larger universities or
agencies that may provide other support to achieve critical
mass.
Looking at the number of PhDs, only 26% of institutions
have at least three full time equivalent at this level (figure
4). A total of 49% have between 1 and 2 and 24% have
none. While the proportion of institutions with 3 or more
PhDs is similar across income groups, that for institutions
with no PhDs is higher in UMICs (48%), against LICs
with only 14%. The smaller the institution, the larger the
proportion of PhDs (Corr = -0.21), raising concerns as to
the extent to which those with PhDs are training up a cad-
re of junior researchers.
Disciplines available
Institutions report a range of disciplines available, on av-
erage 9 with 20% having between 1 and 5, 44% 5 to 10
and 35% more than 10 (figure 5). However, most institu-
tions (54%) report more disciplines available than con-
tracted researchers, indicating that staff are normally
considered as qualified in more than one discipline. There
is no difference in the average across income regions.
As expected, public health is the discipline most frequent-
ly available within institutions, with 77% of them having
at least one researcher qualified in this field. Interestingly,
economics, statistics and management – all disciplines
very close to HPSR- are present in approximately two-
thirds of institutions. Other highly relevant disciplines
such as sociology and public administration are found in
52% and 49% of institutions, respectively. Anthropology,
political science and psychology are present only in
around one-third of institutions. Better staffed disciplines
tend to have better qualified researchers (Corr = 0.17).
Knowledge production process
Out of the total projects surveyed, 44% are in LICs, 33%
in LMICs and 23% in UMICs (table 4). Projects have an
average duration of 14.3 months, and are of somewhat
longer duration in UMICs with 16.6 months on average,
against 12.5 in LMICs and 14.5 in LICs. Only 24% of
projects have a duration of two years or more, while 34%
have a duration of between one and two years. Projects of
less than a year amount to 42% of the total. Project dura-
tion and amount of funding are fairly correlated, as would
be expected (Corr. = 0.37). On average 76% of projects are
initiated per year, given their short duration. The total
number of researchers per project is 2.8 overall, being
highest for LICs at 3.5 and similar in the other two
regions.
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Project funding
96% of projects report a relationship with a funding agen-
cy outside the institution, while 91% provide specific
amounts. Of them, 91% had only one source and the rest
had a combination, mostly of three sources: international
donors, national government, and private.
Total project funding is $47,600 on average, with an an-
nual flow of funds of $27,000. The differences across
income regions for total average funding per project is of
29% across the extremes, favouring LICs. Differences for
annual project expenditure are less pronounced, with
LMICs showing the largest amount. This is mainly due to
the longer duration of projects in LIC, against the shorter
term in LMIC.
Almost a third of projects (30%) received grants below
$10,000, while 27% received between $10,000 and
$24,999 (figure 6). Only 7% of projects are funded at or
above $100,000, although they account for 54% of total
funding. Only 17% of institutions hold these large grants.
LICs tend to receive a larger proportion of smaller grants
and fewer of the larger ones, although differences are oth-
erwise small across income regions.
Capacity development
Among the activities undertaken by institutions to in-
crease their capacity, raising the awareness of policy issues
and processes by researchers is the one most often under-
taken and with the lowest rate of failure (figure 7). In con-
trast, securing stable sources of funding for HPSR,
although frequently tackled, is considered unsuccessful by
28% of respondents on average. The figure is higher for
LICs and UMICs, at 46% and 50%, respectively.
Engagement with stakeholders
External Boards
The engagement of external boards or advisory bodies is
high, being a practice in 70% of institutions. The range of
participation of stakeholders varies widely but it is gener-
ally narrow: out of 11 key actors, only 29% are represent-
ed on average (Key actors are: consumer/community
groups, funding agencies, government health providers,
international advisors/experts, ministry of finance or
equivalent, ministry of health, other government agen-
cies, other stakeholders, own research staff, academic in-
stitutions, private/NGO health providers). Health
authorities and own staff are most often included in these
advisory or governance mechanisms (35% of cases),
Figure 3
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followed by government, international experts and other
government bodies (25% of cases). Financing agencies
and NGOs are included in only 8% and 7% of cases,
respectively.
External influence on project portfolio
The research institution is the initiator in only 34% of
projects, while 31% are initiated by a donor agency, inter-
national research partner or by a private contractor. Gov-
ernments initiate in 24% of cases (table 4). 12% of
projects are reported as a mix of the above. Interestingly,
in UMICs, governments initiate projects in only 14% of
cases, against 22% in LICs and as high as 38% in LMICs.
Furthermore, initiation by own institution is higher in
LICs, with 38%, against only 30% in UMICs. In this latter
group of countries, institutional engagement in private
contracting and a mix of modalities is more prevalent
than in the other regions.
International donors are the most important influence in
terms of number of projects funded, with 60% of the total,
while governments fund 30% and private and other
sources 10%. However, governments fund at highest
levels, with $54,148 per project on average, followed by
international donors with $43,215 and private and other
sources with $23,600. (As indicated earlier, governments
may use donor funds). International donors provide larg-
er grants on average in LICs ($61,728) than in the other
two regions, contrasting with the much lower size of gov-
ernment funding. Grants in LICs have longer duration
than in other regions and are therefore lower in terms of
annual spending. LMICs have the greatest share of
projects funded by governments, with 45% of the total, al-
though these are of shorter duration. LMICs appear able
to attract larger grants on average from international do-
nors when compared to UMICs, while relying on a larger
proportion of government grants. The share of privately
funded projects is similarly low across regions, but the
amounts vary widely, being lowest in LMICs.
Impact on policy making
With respect to perceptions of the impact of research on
policy making, only 34% of respondents consider this be-
low expectations and 2% believe they are not successful in
ensuring awareness of research results and recommenda-
tions by stakeholders. In spite of the marked client
Figure 4
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orientation of research projects as evidenced by source of
project funding, only 46% of institutions target special da-
tabases or publications to policy makers, suggesting a
rather academic orientation of final products and a weak
provider-client relationship even when projects are
government-financed.
Activities to improve stakeholder engagement
Respondents were asked specifically to confirm engage-
ment in a series of activities and to rate their success (fig-
ure 8). Ensuring awareness of research results and
recommendations by policy stakeholders is the activity
most often undertaken and with the lowest reported rate
of failure. Assessing the impact of research on policy and
gaining community-wide recognition for the institution/
unit as producers of high quality, objective HPSR are the
activities least undertaken and reported to be least
successful. The data suggest that respondents are generally
confident of their efforts to strengthen stakeholder en-
gagement, although this view, placed in the context of
other findings, suggests rather limitations in strategic
planning and an overoptimistic view.
Extrapolations and Total Funding
Researchers and projects
With the caveats stated in the methodology, the results
were extrapolated to the estimated population of 649
HPSR producer institutions in low and middle income
countries identified by the Alliance (table 5). The total
workforce dedicated to HPSR can be estimated at 5,471
researchers. The researcher density is lowest in LMICs,
with 0.7 researchers per million inhabitants, against 2.2 in
UMICs, a threefold difference, and 1.2 in LICs. The total
PhDs are 1,009, of which 588 would be in LICs. There
would be in total 1,942 projects, of which 1,476 are initi-
ated per year. Out of all active projects, donors or contrac-
tors initiate the highest number, at 598.
External funding
The research portfolio in the total population of institu-
tions is estimated to be worth $91 million. Of this total,
international donors fund 68% or $62 million, govern-
ments 27% ($24 million), and private and other (nation-
al) sources 5% ($5 million). Direct funding by
international donors dominates in LICs, with 89% of the
total against 4% from governments and 7% from private
sources. International funding is also large in UMICs
Figure 5
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although more balanced with government funding (60%
vs. 34%), while in LMICs governments are the predomi-
nant source, contributing 53% of project funds.
Annual project funding can be estimated at $58 million,
with international donors accounting for $39 million,
governments for $16 million and private and other
(national) sources for $2 million. International donors
provide 53% of their annual resources to LICs, 25% to
LMICs and 22% to UMICs. Of total government funding,
67% is allocated in LMICs.
Equity of funding distribution
LICs spend on average $96 per 10,000 inhabitants, LMICs
$113, and UMICs $223. The main explanation for differ-
ences between the three regions is government funding, as
this source is estimated to contribute $6 per 10,000 in-
habitants in LICs, against $58 in LMICs and $64 in
UMICs, a 10 fold difference between the extremes. Inter-
national sources help to redress the balance between LICs
and LMICs, spending $85 per 10,000 in the former and
$53 in the latter, in spite of the lower average project fund-
ing offered to LICs. However, international funding fur-
ther compounds inequality when UMICs are considered,
which receive $144 per 10,000 inhabitants.
The share of research project funding relative to total
health expenditure is 0.007% for developing countries in
general, with 0.007% and 0.005% for LMICs and UMICs,
respectively, and, interestingly, 0.013% in LICs, about
three times higher than in UMICs. This is explained most-
ly by the much lower annual per capita health expenditure
in LICs, at $76 as compared to $240 for the other two re-
gions combined. The funding effort in LICs vis-à-vis what
would be expected from per capita health expenditure is
therefore greater by a magnitude of five.
Discussion
Methods
The findings of this study must be interpreted in the light
of the data and methods used. The data were obtained
from a questionnaire completed by institutions and fol-
lowed up only for projects with funding in excess of
$100,000. Although the questionnaire was piloted before-
hand and simplified to the extent possible, the nature of
the information sought on research projects and funding
may have been difficult to complete, especially for the
larger institutions and those which lack good information
systems. It was not possible to distinguish between fund-
ing for research by governments derived from national or
international sources. The questionnaire focused on key
Figure 6
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features of the research institutions and of research
projects, potentially omitting important aspects of
institutions such as external support to capacity develop-
ment not linked to research projects. Indicators of capaci-
ty must be regarded as tentative, given lack of knowledge
of what constitutes an ideal level of capacity. Moreover,
the data provide a cross-sectional picture, thus limiting
the extent to which they can provide evidence of changes
over time in institutional size and characteristics. Finally,
although the number of countries and institutions repre-
sented in the income and regional groupings were reason-
ably substantial, it is nonetheless possible that some of
the country grouping comparisons are affected by the par-
ticular characteristics of the countries represented, most
notably China and Colombia in the case of LMICs.
Institutional and country context
In spite of the evident activity across a large number of de-
veloping countries, HPSR is still at very low levels as ap-
parent from the low researcher density and low spending
as a proportion of total health expenditure. However, ref-
erence standards are lacking for a more objective assess-
ment. It is of concern that the total annual HPSR funding
estimated in this study represents only 0.007% of health
expenditure, a ratio that would not be altered significantly
even allowing for a large downward error and for invest-
ments in the North directly benefiting the South. The
Commission for Health Research for Development rec-
ommended that total health research expenditure in the
South should be at the same level as developed countries
with respect to total health expenditure, that is, at about
2%. If HPSR accounts for 5% of this total, a figure very
likely below what occurs in practice, this norm would
place HPSR at 0.1% of total health expenditure. Current
HPSR expenditure at 0.007% is then 14 times below this
norm. Even if all of the research funding available through
multilateral agencies were to be disbursed and spent with-
in developing countries (see below), actual spending
would be 0.012%, that is 8 times below the stated norm
of 0.1%.
If core funding to institutions were included, actual
spending would increase. While it is not possible to esti-
mate by how much, it is worth considering that project
funding is likely to be over 50% of total funding, given
Figure 7
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that average project funding per researcher is higher than
annual salaries.
Institutional characteristics and capacity
HPSR producer institutions are generally small. The pro-
portion of institutions under one year old, about 6%, sug-
gests an expanding field. Private non profit and mixed
public private entities have an important role in the con-
stellation of HPSR producers, particularly in upper middle
(mainly Latin America) and low income countries, where
they account for almost half the total. While a more de-
tailed analysis is warranted, the somewhat larger research
workforce of private institutions points to their capacity to
attract resources and to be sustainable.
LICs, and particularly African institutions, are the least ex-
perienced and thus have the least intra-regional peer sup-
port. Furthermore, new institutions are generally led by
relatively inexperienced researchers. The longer institu-
tions have been in existence, the greater tends to be both
the number of researchers and the size of the project port-
folio, though growth appears to involve the recruitment of
less qualified researchers rather than researchers with Ph-
Ds. Access to computers is a major concern in LICs and re-
liability of internet access should be the subject of further
study.
It is interesting to note the higher proportion of full time
and PhD-qualified researchers in LICs relative to higher
income countries. Further investigation is required to ex-
amine to what extent this is influenced by demand side
versus supply side factors. On the one hand there may be
a lack of competing job opportunities for researchers
trained at the PhD level in this region, meaning that those
trained are retained by their institutions; on the other
hand there may be greater access to funding for PhD stud-
ies in LICs. It is encouraging that LICs do not have the
lowest researcher to population ratio. However, project
funding per researcher does not reward the greater capac-
ity suggested by the data, being in LICs only 2/3 the value
of that of LMICs. The fact that the proportion of PhDs is
inversely correlated to the size of the researcher workforce
may suggest that PhDs favour smaller institutions,
possibly offering better pay and entrepreneurial opportu-
nities. The data suggest a trend where newly qualified
PhDs are establishing small yet dispersed research and
consulting units in both the public and private sectors.
Figure 8
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Attaining critical mass
With only 26% of institutions having 3 or more PhDs
(tentatively about 170 in developing countries as a whole)
and only 15% with research portfolios over $100,000,
most institutions appear to be far from achieving what
might be regarded as a critical mass. It is encouraging that
institutions in LICs have a significantly larger concentra-
tion of researchers and somewhat higher proportion of
PhDs and that project teams tend to be larger than in
higher-income countries. However, the encouraging find-
ings on the higher proportion of PhDs in LICs relative to
other regions has to be tempered with Alliance funding
experience that suggests that PhDs across all regions are
not more successful in obtaining research funding than re-
searchers with only Masters' training [17]. Furthermore, a
large number of institutions in LICs suffer from important
information technology restrictions.
It is encouraging that the key disciplines for HPSR of eco-
nomics, statistics and management are present in at least
two thirds of institutions across income groups, and
researchers specialized in these subjects tend to be better
qualified.
Efficiency in the knowledge production process
In view of the low concentration of key resources, it is
troubling that most projects in the research portfolio are
of short duration, with an average of just over a year, and
Table 4: HPSR Project Characteristics
TOTAL Per Capita GNP
Low Low Middle Upper Middle
No. % No. % No. % No. %
Total projects 321 140 106 75
Duration 
average 
(months)
14.3 16.6 12.7 16.9
FTE per 
project
2.8 3.5 2.4 2.3
% projects 
over 1 year
76 71 79 72
Project funding
% with 
project 
funding
96% 92% 99% 97%
Average all 
sources
$47,638 $51,277 $49,338 $37,083
Internation-
ally funded
$43,215 $61,728 $51,455 $35,446
Government 
funded
$54,148 $10,476 $58,356 $46,250
Privately/
other funded
$23,600 $43,250 $5,000 $21,500
Annually per 
project
$27,030 $24,816 $31,141 $24,725
Project initiation by source, within groups
Donor/con-
tractor/
research 
partner
99 31 45 32 23 21 29 38
Government 78 24 30 22 40 38 11 14
Own 
institution
108 34 54 38 31 29 23 30
Mix/Other 37 12 11 8 12 12 13 17
Projects funded by source, within groups
International 193 60 101 72 47 44 47 62
Government 96 30 27 19 48 45 20 27
Private & 
Other
33 10 13 9 11 11 8 11
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Table 5: Total Resource, Project and Funding Extrapolations
TOTAL Per Capita GNP
Low Low Middle Upper Middle
No./ $ % No./ $ % No./ $ % No./ $ %
Total 
researcher 
FTEs
5471 100 2841 52 1342 25 1288 24
Researchers 
per million
1.1 1.2 0.7 2.2
Total PhDs 1009 100 588 58 235 23 186 18
Total projects 1942 100 823 42 568 29 551 28
Total initi-
ated per year
1476 100 625 42 454 31 391 27
Project initiated by
Donor/con-
tractor/
research 
partner
598 31 266 32 121 21 210 38
Government 469 24 177 22 215 38 79 14
Own 
institution
651 34 317 38 165 29 166 30
Mix/Other 224 12 63 8 66 12 96 17
Number of projects funded, within groups
International 1151 59 575 70 251 44 347 63
Government 594 31 170 21 257 45 143 26
Private & 
Other
198 10 78 9 60 11 61 11
Project 
funding*
$91 100 $40 44 $30 33 $21 23
Within country groups
International $62 68 $36 89 $14 46 $12 60
Government $24 27 $2 4 $16 53 $7 34
Private & 
Other
$5 5 $3 7 $0 1 $1 6
By sources
International 100 58 22 20
Government 100 6 65 29
Private & 
Other
100 64 7 29
Annual 
funding
$58 100 $23 41 $21 37 $13 23
By sources
International $39 100 $21 53 $10 25 $8 22
Government $16 100 $1 9 $11 67 $4 23
Private & 
Other
$2 100 $1 51 $0 11 $1 37
Annual per capita HPSR funding × 10,000
International $80 $85 $53 $144
Government $33 $6 $58 $64
Private & 
Other
$5 $5 $1 $15
Total $117 $96 $113 $223
HPSR 
project 
funding as % 
of THE**
0.007% 0.013% 0.007% 0.005%
All funding figures in millions of dollars except where noted. *Includes total funding for the duration of the project. **THE: Total Health Expendi-
ture. Source: WHO National Health Accounts for 1998.
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that it is therefore likely that much of the research
portfolio is being renewed on a yearly basis. Furthermore,
there are few researchers per project initiated. The capacity
to produce high quality research is likely to be affected by
the need to prepare new applications. Indeed, the low sal-
aries in low income countries require researchers to seek a
constant flow of projects in order to generate an income
sufficient to live on. Projects are not only of short dura-
tion, particularly in LMICs, and involving relatively few
researchers per project, but also small in terms of funding
at $27,000 per project per year on average.
The estimates of total project funding, at $90.5 million for
the project portfolio and $58 million on an annual basis,
have to be considered as preliminary pending more accu-
rate estimations, although the error is not likely to be too
large. International donors account for about 68% of the
total. Their higher share of 89% in LICs offsets the lower
contributions by governments and pushes funding up to
achieve fairly similar average project funding across the
three regions and fairly similar per capita funding across
LICs and LMICs. Anecdotal evidence suggests that costs
for undertaking similar research are higher in Africa and
Latin America than in Asia.
Bilateral overseas development assistance is the most like-
ly source for the international funding. While internation-
al foundations also play an important role in funding
health research, it is likely that much of their funding is on
disease or population-group-specific health services re-
search rather than on system wide issues. Multilateral
funding, particularly by development banks and other
agencies, would be mostly disbursed through national
governments and thus would account for an unknown
proportion of the amounts reported here as coming from
national governments.
Bilateral assistance for health research of all types in devel-
oping countries has been estimated in other studies at
$350 million for 1998 [16]. The annual sum estimated for
international HPSR funding in this study, at $36 million,
would account for 10.3% of these sources (if they were
maintained at the same level for 2000/01), although this
percentage would be somewhat lower if the contribution
by foundations was added to the bilateral total.
Project funding by governments to HPSR producer insti-
tutions in developing countries may account for only a
small part of the funding actually available to them for
HPSR. The amount estimated here of $16 million spent
annually is much lower than the amounts that
development banks earmark for HPSR as part of their
health lending. World Bank lending for health research
was estimated for 1998 at $55.8 million, or 4.7% of total
health lending approved for the year. Most of these funds
are earmarked for policy and health systems research by
developing country researchers and institutions [[16], p
36]. (While a small amount of the $55.8 million funding
would go to European countries as well as for research ar-
eas outside HPSR, there are other multilateral funding
sources not considered which would tend to compensate
for this). Therefore, there is about 3 times as much fund-
ing earmarked for HPSR from government sources than is
actually identified here as spent through national institu-
tions. If this gap were closed, total HPSR spending at the
national level would more than double.
It may be that this multilateral support for HPSR is either
spent outside the country through contracting agencies in
the North or is not spent in spite of being earmarked with-
in development projects. Indeed, the small size and low
critical mass of most national institutions would often not
be appropriate to compete with the North nor to meet the
administrative requirements associated with such con-
tracts. Anecdotal evidence suggests that a large part of gov-
ernment resources made available by multilateral
institutions and earmarked for HPSR may go unspent due
to the low priority to research assigned by decision mak-
ers, the lack of capacity to undertake the competitive ten-
dering required and the lack of competitive bidders
[18,19].
Engagement with stakeholders
In spite of the marked engagement of external actors at the
project level, stakeholders are being involved at the insti-
tutional level only modestly, with a limited range of ac-
tors, little influence at policy levels and low production of
tailor-made databases and publications directed to deci-
sion-makers. Despite this, institutions are in most cases
confident of their success in implementing strategies to re-
late to stakeholders and to obtain funding. This percep-
tion warrants further research as it may rather reflect a low
level of strategic planning and of expectations. The near
total absence of international and private actors on advi-
sory boards is noteworthy.
The relative influence of donors and contractors on
project activity can be appraised in terms of their level of
involvement in project initiation. In general, for every one
project initiated by international donors or contractors,
they fund 1.9 projects. This indicator is similar across the
three regions, ranging from 2.2 in LICs to 1.7 in UMICs.
Thus local project initiation, especially by the research
institution, is more common than might be expected from
the pattern of research funding. Furthermore, project ini-
tiation by international donors/contractors vis-à-vis other
actors is relatively similar across the three regions, suggest-
ing that HPSR in LICs is no more donor-driven than in
better-off countries. However, international donors have a
higher level of project funding in LICs, helping offset
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lower contributions by other actors and leading to similar
project activity levels between LICs and middle income
countries combined.
In spite of the fact that government policy makers and
service providers will be the main beneficiaries of re-
search, they fund only a third of total projects, although
this proportion is higher in LMICs. This may be possibly
due to the larger demand from health sector development
projects in LMICs. Private funding is modest but signifi-
cant and at a similar level across regions.
Notwithstanding the impact of donors on the distribution
of research funds by region and their support to govern-
ment and institution-initiated projects, the predominant-
ly small grants funding is unlikely to encourage the kind
of longer duration, quality research conducive to the es-
tablishment of specialised programmes of national and
international significance and with capacity to relate to
policy makers. On the other hand, it needs to be acknowl-
edged that the small size and low capacity of most institu-
tions would not allow larger grants. Partnerships between
institutions such as those advocated by the Alliance might
overcome part of this problem.
Conclusions
This paper has identified a low volume of funding for
HPSR in developing countries. It is likely that the main
problem is not availability of funds per se, but rather the
constraints imposed by the weak institutional capacity
and lack of critical mass of most institutions. Nonetheless,
appropriate project funding is crucially related to capacity
strengthening, as it stimulates training and institutional
development as well as provides the critical experience to
consolidate research skills.
Current patterns of project funding, on average character-
ised by short term efforts and $27,000 per annum fund-
ing, mainly from international donors, seem to be
associated with small institutions, a good proportion of
which are in the private sector. Such small units may be
failing both to achieve critical mass for quality, sustaina-
ble research and to relate effectively to government policy
development needs. Most institutions are further bur-
dened with the imperative of renewing their project port-
folio almost on a yearly basis. Further research is required
to identify the public-private collaboration and network-
ing which, evidence from Latin America suggests [20,21],
may place larger private entities in an advantageous
situation.
In spite of substantial funding by governments in LMICs
and UMICs, this source has the greatest potential to in-
crease allocations given the resources available from mul-
tilateral agencies for HPSR as part of their health sector
lending. This source has the greatest capacity to break the
vicious circle between small institutional size and small
grants, as well as to allocate funds equitably across re-
gions. However, such funding by itself would not be
enough to ensure the most effective involvement by the
research community in policy development. This requires
increasing the capacity of both governments and research-
ers to demand and provide scientific evidence.
From a methodological perspective, the study points to
the usefulness of indicators such as the number of re-
searchers and their qualifications, proportion of PhDs and
the range of disciplines. The cut-off points here suggested
as indicative of critical mass are very tentative. None-the-
less, it is revealing that while the range of disciplines re-
ported is quite broad for many institutions, the concentra-
tion of researchers, the number of PhDs and their
proportion relative to the total researcher workforce are
more helpful in categorising institutions. The impact of
these variables on project portfolio funding and particu-
larly on publications and engagement with stakeholders
needs to be further analysed. Furthermore, the interaction
between these indicators and country context needs to be
assessed on the basis of more solid outcome indicators.
For example, greater researcher concentration and similar
levels of PhD training in LICs as compared to other re-
gions may not be sufficient to ensure similar quality and
impact of research, particularly given lower government
funding.
Barriers to disbursement of government funding and to ef-
fective stakeholder engagement need to be further ana-
lysed to understand the role of various factors at play,
including the design of research as a part of health sector
development projects, the capacity to identify and target
research needs, the role of competitive tendering and peer
review of research proposals, institutional capacity to sub-
mit quality proposals and the role of international techni-
cal co-operation. In particular, other evidence suggests the
importance of strategically integrating research into the
health system functions of stewardship and service deliv-
ery to ensure government support for research [18,22,23].
International funding, advocacy and technical support
agencies need to identify the best roles and opportunities
for collaboration to offer the right incentives and to
develop appropriate programmes which support the
consolidation of HPSR demand and supply capacity in de-
veloping countries.
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